With offices/creative studios in Hartford, South Norwalk and New Haven, MediaVision Creative does brand storytelling, internal and external communications, and education and training content creation for global corporations, start-ups and non-profit organizations in the health care, and life sciences space. We partner with our clients to ideate, create and distribute print, digital and video communications that raises awareness, sparks emotion, creates connection and helps deepen engagement.
Our team is passionate about collaborating with companies and organizations that are at their core, doing good in the world. As such, we’re privileged to be a trusted creative partner for producing communications that breaks through the clutter, helps our clients execute on mission and makes a positive impact in the lives of those they serve.
MediaVision Creative is a wholly owned subsidiary of CT Public Broadcasting
nextSource transforms how businesses design and execute workforce strategies – delivering agile, data-driven and high-impact talent solutions that go beyond the traditional contingent workforce management services. We partner with organizations to optimize their entire workforce ecosystem, ensuring scalability, compliance, and a competitive edge in a rapidly evolving world of work. nextSource is a certified WBE company.
Research Activities:
nextSource conducts research into economic issues and trends that affect the industries that we serve. Based on this research, nextSource regularly publishes blogs, white papers, and research abstracts.
Detect is a medical device manufacturer involved in the design, manufacturing, and assembly of in vitro diagnostic equipment and tests.
Detect is a biotechnology start-up, founded in 2018, focusing on scaling innovative, rapid, accurate and accessible diagnostics at the point of need. The company was founded by Dr. Jonathan Rothberg who is best known for his contributions to next-generation DNA sequencing and was awarded a National Medal of Technology and Innovation by President Obama in 2016.
SteepRock, Inc. is a global technology leader serving biopharmaceutical and medical device companies as a trusted partner. Our purpose is transforming communication between healthcare manufacturers and providers by delivering critical insights about diseases, diagnoses, costs, treatments, insights, sentiments, trends and management approaches that directly improve patient outcomes and safety.
We leverage our cutting-edge SaaS platforms and AI-powered analytics to convert complex healthcare data into actionable intelligence that drives better marketing, engagement, knowledge capture helping healthcare providers to make better clinical decisions and manufacturers to develop and target their markets more quickly to better serve patients. We continually push the boundaries of innovation in artificial intelligence, developing proprietary algorithms and frameworks that extract deeper insights from healthcare data than previously possible.
Research Activities:
SteepRock is committed to continuous innovation and research. We are a firm at the intersection of technology and healthcare and are dedicated to revolutionizing the way life sciences companies and patients engage with their health. By leveraging our main research activities 1. artificial intelligence 2. machine learning and 3. data analytics, SteepRock aims to enhance patient outcomes and streamline healthcare processes. We collaborate with industry leaders, academic institutions, and healthcare organizations to stay at the forefront of advancements that can transform patient care.
Our mission is to empower healthcare providers and patients through innovative technology solutions. Our services improve access to care, enhance clinical decision making, and promote pro-active health management. Quality and compliance are foundational to Steeprock’s operations. We adhere to the highest standards of data security and patient privacy, ensuring that our solutions meet regulatory requirements while delivering exceptional service to our users. We strive to create a healthier future by delivering tools that facilitate effective communication, informed choices and personalized care.
As the 55th largest accounting firm in the nation, Grassi is a leading provider of advisory, tax and accounting services to businesses and individuals. Grassi advisors specialize in providing industry-specific business consulting, audit, tax, and technology services to key market sectors, including construction, architecture and engineering, not-for-profit, healthcare, manufacturing and distribution, financial services, real estate, cannabis and more.
With offices in New York, New Jersey, Massachusetts and Florida, the firm has the depth of knowledge and experience to work effectively alongside clients across the East Coast region and throughout the United States, as well as internationally through its membership in PrimeGlobal. Visit www.grassiadvisors.com for more information.
OEM Group is a life science focused advertising agency. We specialize:
New Product Launch Plans
OEM Group specializes in creating high-quality, impactful brands with a focus on omnichannel enablement and go-to-market acceleration. We:
Early-stage commercial life science and biotech
We provide corporate strategy, identity and MOA/MOD story telling for startup and early-stage life science and biotech.
Bio X Cell manufactures antibodies for use in in vivo and in vitro research. We serve both the public and private research sectors.
Our historic hotel is off I-95, short and easy commute to downtown New Haven, Yale University, District NHV, Union Train Station, Tweed New Haven airport, restaurant, retails shops and cultural attractions. We’re proud to be a sustainable, fossil fuel-free, all electric hotel celebrating modern design.
Tailored to the building’s original floor plan, our 165 New Haven hotel rooms and suites offer generous views and a sense of calm and quiet through custom interiors with minimalist, interlocking elements and contemporary artwork. Mid-century spaces retain iconic Bauhaus modernist vibes with carefully restored finishes and refined craftsmanship. All guest rooms provide up-to-the-moment technology for a highly personalized stay.
Our onsite restaurant, BLDG, is open for breakfast, lunch, dinner and drinks daily. Guests come to enjoy locally inspired dishes paired with a thoughtful beverage program.
Hotel Marcel also offers full-service event planning and catering service providing landmark New Haven meetings and events for all personalities and occasions.
BioCT members receive an exclusive 15% discount on hotel reservations. Please click here.
Bio X Cell manufactures antibodies for use in in vivo and in vitro research. We serve both the public and private research sectors.
Ommio Health is a biotechnology company with a proprietary platform focused on developing novel therapeutics and biomaterial coatings that improve human health and well-being. Ommio Health is derived from the Greek “omoiostasia” or homeostasis. Many illnesses and health challenges are the direct result of our biological systems deviating from this delicate balance, and we target classes of compounds that have shown promise in impacting health outcomes. Ommio Health is focused on applying our platform to naturally derived therapeutics that have been validated as safe and effective for the modulation of biological systems. Our platform allows us to improve and refine the properties of these compounds for specific outcomes, creating better solutions for human health and well-being. Our initial areas of focus include a therapeutic candidate for various forms of epilepsy and a novel antibacterial coating for applications into urology, including catheters and ureteral stents.
Ommio Health is a biotechnology company with a proprietary platform focused on developing novel therapeutics and biomaterial coatings that improve human health and well-being. Ommio Health is derived from the Greek “omoiostasia” or homeostasis. Many illnesses and health challenges are the direct result of our biological systems deviating from this delicate balance, and we target classes of compounds that have shown promise in impacting health outcomes. Ommio Health is focused on applying our platform to naturally derived therapeutics that have been validated as safe and effective for the modulation of biological systems. Our platform allows us to improve and refine the properties of these compounds for specific outcomes, creating better solutions for human health and well-being. Our initial areas of focus include a therapeutic candidate for various forms of epilepsy and a novel antibacterial coating for applications into urology, including catheters and ureteral stents.